Dissecting the heterogeneity of schizophrenia outcomes

Schizophrenia Bulletin

Volumn 34, Issue 2, 2008, Pages 247-248

  McGrath, John ^a,b  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Epidemiology; Outcome; Schizophrenia

Indexed keywords

DEVELOPING COUNTRY; FOLLOW UP; HUMAN; NEGATIVE SYNDROME; NOTE; OUTCOME ASSESSMENT; POSITIVE SYNDROME; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL STATUS;

DISABILITY EVALUATION; HUMANS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 40049100811     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm133     Document Type: Note

References (23)

1. McGrath JJ. Myths and plain truths about schizophrenia epidemiology-the NAPE lecture 2004. Acta Psychiatr Scand. 2005;111:4-11.
2. McGrath JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull. 2006;32:195-197.
3. McGrath JJ. The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry. 2007;64:14-16.
4. Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr Bull. September 28, 2007; doi:10.1093/schbul/sbm105.
5. Hopper K, Wanderling J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophr Bull. 2000;26:835-846.
6. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992;20:1-97.
7. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370.
8. McGlashan TH. Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry Suppl. 1998;172:3-6.
9. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.
10. Hafner H, An der Heiden W. Course and outcome of schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Cambridge, UK: Cambridge University Press; 2003:101-141.
11. Andreasen NC, Carpenter WT Jr., Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-449.
12. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131.
13. Saha S, Welham J, Chant D, McGrath J. Incidence of schizophrenia does not vary with economic status of the country: evidence from a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2006;41:338-340.
14. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.
15. Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry. 2005;10:27-39.
16. Tishkoff SA, Kidd KK. Implications of biogeography of human populations for 'race' and medicine. Nat Genet. 2004;36:(suppl):S21-S27.
17. Balaresque PL, Ballereau SJ, Jobling MA. Challenges in human genetic diversity: demographic history and adaptation. Hum Mol Genet. 2007;16(Spec No. 2):R134-R139.
18. McGrath JJ. The romance of balancing selection versus the sober alternatives: let the data rule (commentary on Keller and Miller). Behav Brain Sci. 2006;29:417-418.
19. Spitz MR, Wu X, Mills G. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol. 2005;23:267-275.
20. Waters RJ, Nicoll JA. Genetic influences on outcome following acute neurological insults. Curr Opin Crit Care. 2005;11:105-110.
21. Murray CJ, Lopez AD. The Global Burden of Disease. Boston, Mass: Harvard School of Public Health; 1996.
22. Lopez AD. The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Global Health. 2005;1:5.
23. Murray CJ, Lopez AD, Black R, et al. Global Burden of Disease 2005: call for collaborators. Lancet. 2007;370:109-110.